General Information of the Compound
| Compound ID |
CP0461241
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-(2-(3-methoxyphenyl)-1-phenylethyl)piperazine
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-(2-(3-methoxyphenyl)-1-phenylethyl)piperazine
1-[2-(3-Methoxyphenyl)-1-phenylethyl]piperazine
61311-72-6
BDBM50188044
CHEMBL212763
CTK2E2732
DTXSID40552210
Piperazine, 1-[2-(3-methoxyphenyl)-1-phenylethyl]-
SCHEMBL11504855
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H24N2O
|
||||||||||||||||||
| Molecular Weight |
296.414
|
||||||||||||||||||
| Canonical SMILES |
COc1cccc(CC(N2CCNCC2)c2ccccc2)c1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H24N2O/c1-22-18-9-5-6-16(14-18)15-19(17-7-3-2-4-8-17)21-12-10-20-11-13-21/h2-9,14,19-20H,10-13,15H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
CTAHXNUPBZTDFO-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00884, Sodium-dependent dopamine transporter
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Protein ID: PT00871, Sodium-dependent serotonin transporter
Clinical Information about the Compound